Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
Retraction Pfizer, Inc., has recently learned that the overall response rate and progression-free survival data published in “Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871
Add to Reading List
Document Date: 2012-10-24 19:18:58
Open Document
File Size: 31,93 KB
Share Result on Facebook
Retraction Pfizer, Inc., has recently learned that the overall response rate and progression-free survival data published in “Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871